Our data show that the human GLP-1 analogue liraglutide improves hyperglycemia concomitantly with increased beta cell mass and insulin secretion when administered daily for 30 days to alloxan-induced diabetic mice. The gene discussed is GCG; the disease is Hyperglycemia.